Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Antivet is a microabrasion kit used for the treatment of dental fluorosis, specifically designed to remove brownish stains on tooth enamel caused by excessive fluoride intake. The kit, manufactured by Dental Continental, contains a 21% acid solution—identified in some clinical contexts as hydrochloric acid and in others as hydrofluoric acid—that acts as a chemical microabrasive to separate fluoride ions from fluorotic areas of the enamel. The treatment is a topical, one-visit procedure that involves applying the cleaning solution to the affected teeth with a brush or swab, followed by the application of a neutralizing solution for two minutes to halt the chemical action. It is also recommended as a pre-orthodontic treatment to improve bracket adhesion on teeth affected by fluorosis. Cairo University has conducted Phase 4 clinical trials evaluating Antivet's performance in managing mild to moderate fluorosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Antivet.